The pathological confirmation rate of lung cancer in England using the NLCA database

Lung Cancer

Volumn 79, Issue 2, 2013, Pages 125-131

  Khakwani, Aamir ^a   Rich, Anna L ^b   Tata, Laila J ^a   Powell, Helen A ^a   Stanley, Rosamund A ^c   Baldwin, David R ^b   Hubbard, Richard B ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c Health and Social Care Information Centre   (United Kingdom)

Author keywords

Cytology; Histology; Lung cancer; Pathology; Performance status; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CYTOLOGY; FEMALE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NATIONAL LUNG CANCER AUDIT; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY CONTROL;

AGE FACTORS; AGED; AGED, 80 AND OVER; BENCHMARKING; CARCINOMA, NON-SMALL-CELL LUNG; CONFIDENCE INTERVALS; ENGLAND; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; REFERRAL AND CONSULTATION; SMALL CELL LUNG CARCINOMA;

EID: 84872136983     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.11.005     Document Type: Article

References (16)

1. Crawford S.M., Atherton F. Lung cancer: histological aspects of diagnosis in England and the south east Netherlands. J Epidemiol Community Health 1994, 48(4):420-421.
2. NICE: Lung cancer: the diagnosis and treatment of lung cancer; April 2011.
3. NHSIC: National lung cancer audit report 2011; 2011.
4. NHSIC: National lung cancer audit 2010; 2010.
5. Coleman M.P., Forman D., Bryant H., Butler J., Rachet B., Maringe C., et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011, 377:127-138.
6. Rich A.L., Tata L.J., Stanley R.A., Free C.M., Peake M.D., Baldwin D.R., et al. Lung cancer in England: information from the National Lung Cancer Audit (LUCADA). Lung Cancer 2011, 72(1):16-22.
7. Imperatori A., Harrison R.N., Leitch D.N., Rovera F., Lepore G., Dionigi G., et al. Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival. Thorax 2006, 61(3):232-239.
8. Rich A.L., Tata L.J., Free C.M., Stanley R.A., Peake M.D., Baldwin D.R., et al. Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax 2011, 66(12):1078-1084.
9. Birim O., Kappetein A.P., Bogers A.J.J.C. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg 2005, 28(5):759-762.
10. Asmis T.R., Ding K., Seymour L., Shepherd F.A., Leighl N.B., Winton T.L., et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 2008, 26(1):54-59.
11. Wang C.-Y., Lin Y.-S., Tzao C., Lee H.-C., Huang M.-H., Hsu W.-H., et al. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection. Eur J Cardiothorac Surg 2007, 32(6):877-881.
12. Rich A.L., Tata L.J., Free C.M., Stanley R.A., Peake M.D., Baldwin D.R., et al. How do patient and hospital features influence outcomes in small-cell lung cancer in England?. Br J Cancer 2011, 105(6):746-752.
13. Watkin S.W., Hayhurst G.K., Green J.A. Time trends in the outcome of lung cancer management: a study of 9090 cases diagnosed in the Mersey Region, 1974-86. Br J Cancer 1990, 61(4):590-596.
14. Pirina P., Budroni M., Esposito S., Ostera S., Polo M.F., Santoru L., et al. Cytological and histological diagnosis of lung cancer in Sardinia and Italy in the 1990s. Monaldi Arch Chest Dis 2007, 67(4):179-183.
15. Radzikowska E., Glaz P., Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival population-based study of 20,561 cases. Ann Oncol 2002, 13(7):1087-1093.
16. Crawford S.M., Sauerzapf V., Haynes R., Zhao H., Forman D., Jones A.P. Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer 2009, 101(6):897-901.